#United States #New York #ProofPilot #RealTime #Chris Venezia

Chris Venezia's New Adventure with RealTime eClinical Solutions

In a noteworthy move in the clinical research sector, Chris Venezia, the CEO of ProofPilot, has recently accepted a position on the Board of Directors of RealTime eClinical Solutions. This appointment comes at a critical time for RealTime, as the organization aims to continue enhancing connections between clinical trial sites and sponsors.

Venezia, a veteran in clinical research technology, brings over 20 years of experience in product development, commercialization, marketing, and sales to his new role. Since taking the helm at ProofPilot in 2022, he has successfully steered the company into becoming a leading player in the domain of clinical trials, showcasing his knack for advancing solutions to meet the challenges faced by researchers today.

RealTime eClinical Solutions focuses on redefining the operational backbone of site-based clinical trials through its robust eClinical platform. Their innovative Site Operations Management System (SOMS) integrates various tools like CTMS, eSource, eReg/eISF, and participant engagement into one cohesive system, allowing for increased efficiency and collaboration in clinical operations. This makes them an ideal partner for Venezia, who recognizes the need for technology that aligns with the fast-paced demands of clinical trials.

As RealTime’s new CEO, Jeff Kozloff, stated, “Reducing site burden and accelerating site operations requires sponsors to invest in data and platforms that improve protocol planning, feasibility, and trial execution.” Venezia's rich experience in liaising with sponsors and Contract Research Organizations (CROs) will undoubtedly help unlock significant value for RealTime's global site community.

Venezia commented on his new journey, emphasizing how sponsors are in search of partners capable of adapting to the dynamic landscape of clinical research. He believes that RealTime is poised to meet this demand and is excited to support the team in amplifying the company's technological impact. His vision aligns closely with RealTime's objectives, making this collaboration particularly promising for the stakeholders involved.

ProofPilot continues to modernize the clinical trial process by simplifying site operations and minimizing patient burden. Their platform is designed to provide a seamless experience throughout the clinical trial lifecycle, from initial startup to closeout. Such an approach not only leads to expedited enrollment timelines but also contributes to higher compliance rates and improved overall quality during trials.

As Chris takes on this dual role between both leading ProofPilot and serving on RealTime's Board, the clinical research community eagerly anticipates the innovations and advancements that will emerge from this collaboration. The integration of advanced technology with efficient operational strategies holds the potential to drive meaningful changes across the landscape of clinical trials, benefitting sponsors, sites, and participants alike. The partnership represents a significant step towards creating a more effective, transparent, and responsive clinical trial system.

In conclusion, as the clinical trial landscape continues to evolve, the role of leaders like Chris Venezia becomes increasingly vital. His expertise and leadership will help guide RealTime eClinical Solutions in enhancing their platform, ultimately paving the way for more efficient and effective clinical research practices in the years to come.